Published in Politico Europe, an important and timely article from Annette Bakker (CTF President and CTF Europe Board Chair) on how proposed pharma reforms in the EU are well-meaning but could unintentionally hinder the availability of life-saving drugs to patients. As she writes, “good intentions don’t necessarily translate to good policy”. Click below to learn more about this critical issue, as well as CTF’s development of a preclinical hub and platform trials to more efficiently and quickly get effective treatments to patients.
https://www.politico.eu/article/european-union-pharmaceutical-reforms-hurt-patients-hinder-research/
